BQ Edge | Why You Should Keep An Eye On Biocon’s Stock This Week

BQEdge is specially curated for BQBlue subscribers. Every day this note will offer special equity market and stock-specific insights and flag select emerging trends in the tricky-to-trade derivatives market.On Today’s Edition:Why Biocon — last year’s second-best performing Nifty Pharma stock — may not be done with its up move.